| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 206,583 | -7,757,153 | 1,843,639 | 3,168,205 |
| Amortization of deferred offering costs | - | - | 0 | 0 |
| Accretion of commercial mortgage loans held-for-investment discounts | 482,639 | 381,839 | 356,407 | 1,181,563 |
| Accretion of deferred loan fees | 797,632 | 670,545 | 927,892 | 1,192,902 |
| Depreciation | - | - | - | 138,777 |
| Amortization of deferred offering costs | - | 0 | - | - |
| Amortization of deferred financing costs | 775,839 | 530,358 | 319,000 | 627,596 |
| Provision for credit losses | - | 14,390,927 | - | - |
| (release of) provision for credit losses, net | -6,543,142 | - | -31,664 | 5,842,433 |
| Depreciation and amortization | 304,885 | 295,698 | 483,562 | - |
| Loss on extinguishment of debt | -1,152,861 | - | - | - |
| Loss on sale of real estate owned | - | -547,447 | - | - |
| Real estate owned impairment expense | 1,350,435 | - | - | - |
| Unrealized loss on mortgage servicing rights | -30,245 | -11,367 | -24,700 | -58,974 |
| Non-cash compensation expense | 52,499 | 52,501 | 52,497 | 84,987 |
| Accrued interest receivable | 123,592 | 1,014,665 | -1,221,985 | -310,299 |
| Other assets | -543,631 | -472,165 | 1,130,402 | 542,998 |
| Accrued interest payable | -95,222 | -148,067 | -164,668 | -515,352 |
| Fees and expenses payable to manager | 1,560,000 | -22,825 | -354,762 | 231,869 |
| Other liabilities | -175,694 | 755,483 | 302,178 | 675,136 |
| Net cash provided by operating activities | 3,569,826 | 1,250,083 | 1,142,989 | 7,705,461 |
| Restricted cash assumed from acquisition of real estate owned | - | - | 1,717,750 | - |
| Purchase and funding of commercial mortgage loans held-for-investment | 47,845,148 | 400,172,460 | 0 | 3,605,000 |
| Purchase of real estate owned | 246,437 | -113,605 | 861,706 | - |
| Principal payments from commercial mortgage loans held-for-investment | 62,212,238 | 94,930,675 | 38,150,247 | 118,376,467 |
| Proceeds from sale of real estate owned | - | 8,156,893 | - | - |
| Capital expenditures on real estate owned, held-for-investment | - | 1,095,445 | - | - |
| Proceeds from sale of real estate owned | 381,752 | - | - | - |
| Restricted cash assumed from acquisition of real estate owned | - | -1,522,391 | - | - |
| Capital expenditures on real estate owned, held-for-investment | -191,183 | - | - | - |
| Deferred loan fees | -931,808 | -617,716 | -614,425 | -1,186,611 |
| Net cash provided by investing activities | 15,243,030 | -298,498,267 | 39,620,716 | 115,958,078 |
| Dividends paid on common stock | 2,095,971 | 2,094,597 | 3,140,463 | 13,078,523 |
| Dividends paid on preferred stock | 1,181,250 | 1,188,750 | 1,181,250 | 2,370,000 |
| Proceeds from secured financing agreements | 191,617,908 | 450,960,414 | - | - |
| Proceeds from secured term loan | 2,250,000 | 584,983,000 | - | - |
| Payment of secured financing agreements | 35,019,643 | 256,766,633 | - | - |
| Payment of securitized debt obligations | 169,655,462 | 501,668,124 | 40,343,953 | 119,031,157 |
| Payment of deferred financing costs | 724,505 | 7,205,040 | - | - |
| Net cash (used in) financing activities | -14,808,923 | 267,020,270 | -44,665,666 | -134,479,680 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 4,003,933 | -30,227,914 | -3,901,961 | -10,816,141 |
| Cash, cash equivalents and restricted cash, beginning of period | 26,618,082 | 56,845,996 | 71,564,098 | - |
| Cash, cash equivalents and restricted cash, end of period | 30,622,015 | 26,618,082 | 56,845,996 | - |
Lument Finance Trust, Inc. (LFT-PA)
Lument Finance Trust, Inc. (LFT-PA)